Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors.
Cristina Royo-CebrecosJúlia Laporte-AmargósMarta PeñaIsabel Ruiz-CampsPedro Puerta-AlcaldeEdson AbdalaChiara OltoliniMurat AkovaMiguel MontejoMalgorzata MikulskaPilar Martín-DávilaFabian HerreraOriol GaschLubos DrgonaHugo Manuel Paz MoralesAnne-Sophie BrunelEstefanía GarcíaBurcu IslerWinfried V KernZaira R Palacios-BaenaGuillermo Maestro de la CalleMaria Milagro MonteroSouha S KanjOguz R SipahiSebnem CalikIgnacio Márquez-GómezJorge I MarinMarisa Z R GomesPhilipp HemmattiRafael AraosMaddalena PeghinJosé Luís Del PozoLucrecia YáñezRobert TilleyAdriana ManzurAndrés NovoJordi CarratalaCarlota Gudiolnull nullPublished in: Pathogens (Basel, Switzerland) (2022)
The clinical features and outcomes of PA BSI in neutropenic cancer patients showed some differences depending on the underlying malignancy. Considering these differences and the risk factors for mortality may be useful to optimize their therapeutic management. Among the risk factors associated with overall mortality, IEAT and the administration of granulocyte colony-stimulating factor were the only modifiable variables.